Tudor Investment Corp ET AL Sells 87,253 Shares of EverQuote, Inc. $EVER

Key Points

• Tudor Investment Corp ET AL cut its EverQuote stake by 48.9%, selling 87,253 shares in the quarter and retaining 91,338 shares valued at about $2.09 million (≈0.25% of the company).
• EverQuote beat expectations — reported EPS of $1.54 vs. $0.35 expected and revenue of $195.3M, up 32.3% year-over-year, with strong profitability metrics (ROE 57.65%, net margin 14.34%).
• Analysts pared targets but remain moderately positive: several firms cut price objectives after the results, yet the consensus is a "Moderate Buy" with an average target of $23.83 while the stock trades near $15 (market cap ≈ $544M; P/E ~5.7).

Tudor Investment Corp ET AL reduced its position in EverQuote, Inc. (NASDAQ:EVER - Free Report) by 48.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 91,338 shares of the company's stock after selling 87,253 shares during the quarter. Tudor Investment Corp ET AL owned approximately 0.25% of EverQuote worth $2,089,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. NewEdge Advisors LLC bought a new position in EverQuote in the third quarter worth $52,000. PharVision Advisers LLC bought a new position in shares of EverQuote during the third quarter valued at $209,000. Virtus Advisers LLC lifted its holdings in shares of EverQuote by 1,238.3% during the third quarter. Virtus Advisers LLC now owns 30,005 shares of the company's stock valued at $686,000 after acquiring an additional 27,763 shares during the period. Prelude Capital Management LLC bought a new position in shares of EverQuote during the third quarter valued at $215,000. Finally, Mariner LLC lifted its holdings in shares of EverQuote by 56.2% during the third quarter. Mariner LLC now owns 14,829 shares of the company's stock valued at $339,000 after acquiring an additional 5,337 shares during the period. 91.54% of the stock is owned by institutional investors.

EverQuote Stock Performance

Shares of NASDAQ:EVER opened at $15.09 on Monday. EverQuote, Inc. has a twelve month low of $13.93 and a twelve month high of $28.73. The firm has a market cap of $543.69 million, a PE ratio of 5.72 and a beta of 0.62. The business has a fifty day moving average of $16.01 and a 200-day moving average of $21.42.

EverQuote (NASDAQ:EVER - Get Free Report) last announced its earnings results on Monday, February 23rd. The company reported $1.54 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $1.19. EverQuote had a return on equity of 57.65% and a net margin of 14.34%.The company had revenue of $195.32 million during the quarter, compared to analyst estimates of $176.82 million. During the same period last year, the company posted $0.33 earnings per share. The firm's quarterly revenue was up 32.3% compared to the same quarter last year. On average, analysts anticipate that EverQuote, Inc. will post 0.72 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on EVER shares. Craig Hallum reissued a "buy" rating and set a $20.00 price objective on shares of EverQuote in a report on Tuesday, February 24th. Needham & Company LLC cut their price objective on EverQuote from $40.00 to $25.00 and set a "buy" rating for the company in a report on Tuesday, February 24th. JPMorgan Chase & Co. cut their price objective on EverQuote from $32.00 to $22.00 and set an "overweight" rating for the company in a report on Tuesday, February 24th. B. Riley Financial cut their price objective on EverQuote from $36.00 to $30.00 and set a "buy" rating for the company in a report on Tuesday, February 24th. Finally, Canaccord Genuity Group cut their price objective on EverQuote from $33.00 to $28.00 and set a "buy" rating for the company in a report on Tuesday, February 24th. Six research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $23.83.

Insiders Place Their Bets

In related news, CEO Jayme Mendal sold 14,360 shares of EverQuote stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $14.98, for a total value of $215,112.80. Following the completion of the sale, the chief executive officer directly owned 541,777 shares in the company, valued at $8,115,819.46. This trade represents a 2.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Jon Ayotte sold 1,730 shares of EverQuote stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $15.56, for a total value of $26,918.80. Following the completion of the sale, the chief accounting officer owned 86,202 shares of the company's stock, valued at approximately $1,341,303.12. The trade was a 1.97% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 31,785 shares of company stock valued at $608,623. 25.52% of the stock is currently owned by corporate insiders.

About EverQuote

EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.

The company's core business centers on a quote-comparison engine for personal auto, home, and health insurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.